• OPEN AN ACCOUNT
Indian Indices
Sensex
83,576.24 -604.72
( -0.72%)
Global Indices
Nasdaq
49,520.87 233.75
(0.47%)
Dow Jones
6,986.78 44.32
(0.64%)
Hang Seng
51,918.01 800.75
(1.57%)
Nikkei 225
10,123.15 78.46
(0.78%)
Forex
USD-INR
89.91 -0.02
(-0.02%)
EUR-INR
104.90 -0.20
(-0.19%)
GBP-INR
120.86 -0.43
(-0.35%)
JPY-INR
0.57 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Healthcare Global Enterprises Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
539787
INE075I01017
83.9846452
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HCG
491.62
9011.8
EPS(TTM)
Face Value()
Div & Yield %
1.3
10
0
 

suryoday micro finance ltd
Natco Pharma concludes USFDA inspection of its API unit in Chennai
Nov 21,2025

Natco Pharma today announced conclusion of US FDA Inspection at its Manali, Chennai, Active Pharmaceutical Ingredients (API) Unit. The inspection was conducted from 17 - 21 November 2025.

On conclusion of the inspection, the Company received seven observations in the Form-483. The Company believes that the observations are procedural in nature. The Company is confident to address these observations comprehensively.